Dr. Sanjay Gupta: A New Way to Heal
Doctors have long prescribed pills and procedures. But for some people, that isn’t enough. Sanjay sits down with Julia Hotz, author of The Connection Cure, to explore the…
Thought Leader: Sanjay Gupta
Gottlieb sets a new standard for FDA commissioner
By Scott Gottlieb (Original source Modern Healthcare)
“Dr. Scott Gottlieb has taken industry skeptics by surprise.
When the Trump administration tapped Gottlieb to lead the U.S. Food and Drug Administration last year, branded-drug manufacturers and their investors celebrated. Others were less exuberant.
Industry observers expected Gottlieb, who advised GlaxoSmithKline and was a board member for several other drug and device makers, to protect Big Pharma’s interests.
Yet, about a year later, the FDA commissioner has quieted many of his critics. An unprecedented level of transparency and public disclosure has garnered support from across the industry. Gottlieb has tried to curb drug prices by introducing more generics. The public health community praised his policies that look to lower salt content in food and nicotine in cigarettes, as well as crack down on opioid distributors and websites.”
Click here to see more
Relevant and recent posts
Niall Ferguson: Trump’s World Order Live From Davos
Live from Davos, Scott Galloway and historian Niall Ferguson examine why today’s geopolitical moment looks less like a “new world order” and more like a…
Thought Leader: Niall Ferguson
Mike Pence Talks Trump’s Foreign Policy
Former US VP Mike Pence discusses President Trump’s foreign policy with Greenland, Russia, and Ukraine. He says he commends President Trump on finding a framework…
Thought Leader: Mike Pence
More with this speaker
Dr. Scott Gottlieb on Finding Cures for Rare Diseases
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb: What’s Next for Childhood Vaccines
Thought Leader: Scott Gottlieb
Scott Gottlieb on China’s biotech strategy
Thought Leader: Scott Gottlieb